Published in Am J Transplant on January 06, 2010
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry. Am J Transplant (2012) 1.52
Novel Application of Localized Nanodelivery of Anti-Interleukin-6 Protects Organ Transplant From Ischemia-Reperfusion Injuries. Am J Transplant (2017) 0.76
Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death. Clin J Am Soc Nephrol (2015) 0.75
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation (2005) 1.10
The expanded criteria donor policy: an evaluation of program objectives and indirect ramifications. Am J Transplant (2006) 1.01
Financial incentives for cadaver organ donation: an ethical reappraisal. Transplantation (2002) 1.00
Using a standardized donor ratio to assess the performance of organ procurement organizations. Health Serv Res (2002) 0.90
A positive analysis of financial incentives for cadaveric organ donation. J Health Econ (2001) 0.89
It is time to re-think 'extended criteria'. Am J Transplant (2006) 0.84
Public education and organ donation. Transplant Proc (1997) 0.83
Matching does not improve outcome from aged marginal kidney donors. Transplant Proc (2001) 0.81
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet (1998) 3.24
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis (1997) 2.63
The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant (2006) 2.14
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04
Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04
Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant (2010) 2.02
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab (1997) 1.82
First-pass metabolism of cyclosporin by the gut. Lancet (1991) 1.71
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
CYP3A gene expression in human gut epithelium. Pharmacogenetics (1994) 1.66
Cancer incidence among Canadian kidney transplant recipients. Am J Transplant (2007) 1.66
Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (2004) 1.65
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology (1992) 1.62
The riskiest job in medicine: transplant surgeons and organ procurement travel. Am J Transplant (2009) 1.58
Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58
A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology (1995) 1.56
Preoperative risk factor assessment in liver transplantation. Surgery (1992) 1.55
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
Antibiotics for upper respiratory tract infections. Follow-up utilization and antibiotic use. Arch Fam Med (1999) 1.48
Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant (2010) 1.47
Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors. Am J Transplant (2012) 1.46
Negative words on surgical wards result in therapeutic failure of patient-controlled analgesia and further release of cortisol after abdominal surgeries. Minerva Anestesiol (2008) 1.41
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant (2012) 1.32
TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements. Exp Cell Res (2001) 1.25
Physical activity, physical fitness, and risk of dying. Epidemiology (1998) 1.24
Hand-assisted laparoscopic live donor nephrectomy. Urology (1998) 1.19
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19
Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant (2009) 1.18
Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant (2011) 1.17
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13
Trends in organ donation and transplantation in the United States, 1997-2006. Am J Transplant (2008) 1.10
Risk factors for urinary complications after renal transplantation. Am J Transplant (2007) 1.10
Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant (2007) 1.09
Race and ethnicity in access to and outcomes of liver transplantation: a critical literature review. Am J Transplant (2009) 1.08
Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet (1990) 1.07
microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ. Oncogene (2011) 1.06
Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol (2000) 1.05
Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1. J Invest Dermatol (2000) 1.03
Excess risk of renal allograft loss associated with cigarette smoking. Transplantation (2001) 1.02
SRTR program-specific reports on outcomes: a guide for the new reader. Am J Transplant (2008) 1.02
Sex-based disparities in liver transplant rates in the United States. Am J Transplant (2011) 1.02
Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology (1994) 1.02
An improved mechanical technique for assisted hatching. Hum Reprod (2005) 1.02
PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology (2011) 1.02
Mutation in PITX2 is associated with ring dermoid of the cornea. J Med Genet (2004) 1.01
Liver and intestine transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.00
Mutation analysis of hereditary multiple exostoses in the Chinese. Hum Genet (1999) 1.00
Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant (2006) 0.99
The economic implications of broader sharing of liver allografts. Am J Transplant (2011) 0.98
Presence of antibody against the inducible Hsp71 in patients with acute heat-induced illness. Cell Stress Chaperones (2001) 0.97
Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression. Transplant Proc (1983) 0.96
Prospective, case matched comparison of hand assisted laparoscopic and open surgical live donor nephrectomy. J Urol (2000) 0.96
Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res (2013) 0.96
Innovations in the assessment of transplant center performance: implications for quality improvement. Am J Transplant (2009) 0.95
Two functionally distinct forms of NKX2.1 protein are expressed in the pulmonary epithelium. Biochem Biophys Res Commun (2000) 0.95
Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM). Am J Transplant (2006) 0.94
Aortic revascularization of orthotopic liver allografts: indications and long-term follow-up. Surgery (1993) 0.94
Recent trends and results for organ donation and transplantation in the United States, 2005. Am J Transplant (2006) 0.93
Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membership. Am J Transplant (2009) 0.93
Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases. Am J Med (1991) 0.93
Medication cost information in a computer-based patient record system. Impact on prescribing in a family medicine clinical practice. Arch Fam Med (1999) 0.93
Transplant center regulations--a mixed blessing? An ASTS Council viewpoint. Am J Transplant (2008) 0.93
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant (2008) 0.93
Notch signaling may negatively regulate neonatal rat cardiac fibroblast-myofibroblast transformation. Physiol Res (2011) 0.93
Genome-wide dissection of Fusarium resistance in tomato reveals multiple complex loci. Mol Genet Genomics (2001) 0.92
Estimating residue evolutionary conservation by introducing von Neumann entropy and a novel gap-treating approach. Amino Acids (2007) 0.91
Homozygous loss-of-function mutation of the LEPREL1 gene causes severe non-syndromic high myopia with early-onset cataract. Clin Genet (2013) 0.91
Radon-progeny exposure and lung cancer risk in a cohort of Newfoundland fluorspar miners. Radiat Res (1998) 0.91
The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Transplant (2010) 0.91
Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis. J Viral Hepat (2009) 0.90
Trends in organ donation and transplantation in the United States, 1996-2005. Am J Transplant (2007) 0.89
Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant (2006) 0.89
Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis (2008) 0.89
Corticosteroid withdrawal after liver transplantation. Surgery (1995) 0.89
Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut (1992) 0.87
Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. A 25-year single-center experience. Arch Surg (1995) 0.87
Selective management of penetrating neck trauma. Cost implications. Arch Surg (1981) 0.87
Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (1999) 0.86
Biphasic waveforms for ventricular defibrillation: optimization of total pulse and second phase durations. Pacing Clin Electrophysiol (1997) 0.85
Silica fragments from millet bran in mucosa surrounding oesophageal tumours in patients in northern China. Lancet (1982) 0.85
P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients. Clin Pharmacol Ther (1994) 0.85
Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation. Radiology (1992) 0.85
Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol (1996) 0.84
Attitudes of the American public toward organ donation after uncontrolled (sudden) cardiac death. Am J Transplant (2010) 0.84
Genetics of IgA deficiency. APMIS (1995) 0.84
Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay. Leukemia (2001) 0.84